Recent Articles from GlobeNewswire

BOSTON, June 09, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (“Tango”) (Nasdaq: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced today the pricing of an underwritten offering of 18,166,667 shares of its common stock and pre-funded warrants to purchase up to 1,833,395 shares of its common stock (the “Offering”). The offering price of each share of common stock is $30.00. The offering price of each pre-funded warrant is $29.999, which represents the per share offering price for the common stock less the $0.001 per share exercise price for such pre-funded warrant. The gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering-related expenses, are expected to be approximately $600 million. All of the shares and pre-funded warrants in the Offering are to be sold by Tango. The Offering is expected to close on or about June 11, 2026, subject to customary closing conditions. In addition, Tango has granted the underwriters a 30-day option to purchase up to an additional 3,000,009 shares of common stock at the public offering price, less the underwriting discount.

NEW YORK and NEW ORLEANS, June 09, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NasdaqGS: WGS) (“GeneDx” or the “Company”), if they purchased or otherwise acquired the Company’s shares between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Connecticut.

NEW YORK and NEW ORLEANS, June 09, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until July 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sportradar Group AG (NasdaqGS: SRAD) (“Sportradar” or the “Company”), if they purchased or otherwise acquired the Company’s Class A ordinary shares between November 7, 2024 and April 21, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK and NEW ORLEANS, June 09, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in PicS N.V. (“PicS” or the “Company”) (NasdaqGS: PICS) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, June 09, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until June 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against SES AI Corporation (NYSE: SES) (“SES” or the “Company”), if they purchased or otherwise acquired the Company’s securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Massachusetts.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) --

CAMBRIDGE, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines, Inc. (Nasdaq: PBLS) (“Parabilis”), a clinical-stage biopharmaceutical company built to develop transformative medicines addressing some of the most consequential, yet historically undruggable, protein targets driving human disease, today announced the pricing of its upsized initial public offering of 33,500,000 shares of its common stock at a price to the public of $20.00 per share. In addition, Parabilis has granted the underwriters a 30-day option to buy an additional 5,025,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ:VERI) investors of the July 20, 2026 lead plaintiff deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Veritone securities between October 14, 2025 through April 14, 2026 (“the Class Period”).

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) --

Metamucil is launching “Metamucil Mic Grab,” a new digital content series hosted by Shapiro and featuring 90s icons Lance Bass and Danielle Fishel

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Futu Holdings Limited (“Futu” or the “Company”) (NASDAQ:FUTU) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

Thomas J. Powell, et al. v. Securities and Exchange Commission

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Commvault (CVLT) To Contact Him Directly To Discuss Their Options

Incline Village, NV, June 09, 2026 (GLOBE NEWSWIRE) -- RMG ML Sports Holdings (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company and led by Chief Executive Officer, James Carpenter, and President and Chief Financial Officer, Douglas Horlick, today announced the pricing of its initial public offering of 20,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right to receive one-eighth (1/8) of one Class A ordinary share upon the consummation of the Company’s initial business combination. The units are expected to trade on the Global Market tier of the Nasdaq Stock Market (“Nasdaq”) under the ticker symbol “SHOTU” beginning June 10, 2026. Once the securities comprising the units begin separate trading, the ordinary shares and the rights are expected to be traded on Nasdaq under the symbols “SHOT” and “SHOTR,” respectively.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Phreesia (PHR) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BitGo (BTGO) To Contact Him Directly To Discuss Their Options

CORAL GABLES & SAN FRANCISCO, June 09, 2026 (GLOBE NEWSWIRE) -- With a shared commitment to transforming health care, Baptist Health South Florida, the region’s largest and most preferred healthcare organization, and Amazon One Medical, a hybrid in-person and virtual primary care organization, will collaborate to deliver seamless primary and specialty care in South Florida.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- BlockchAIn Digital Infrastructure, Inc. (NYSE American: AIB) ("BlockchAIn" or the "Company"), a developer and operator of digital infrastructure focused on artificial intelligence ("AI") workloads, announces the closing of its previously announced underwritten public offering of 33,333,334 shares of its common stock at a public offering price of $1.65 per share, for total gross proceeds of approximately $55 million, before deducting underwriting discounts and commissions and other offering expenses. The Company intends to use the net proceeds from the offering for working capital, capital expenditures relating to growing its business, and general corporate purposes.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sportradar (SRAD) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In POET To Contact Him Directly To Discuss Their Options

MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- Imagine, a trusted partner to the world’s most successful brands, today announced that Mike Ritzenthaler has been appointed Chief Financial Officer. He will report to CEO Don McKenzie and be based at Imagine’s Minneapolis headquarters.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PicPay (PICS) To Contact Him Directly To Discuss Their Options

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zoetis Inc. (“Zoetis” or the “Company”) (NYSE: ZTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

KAPALUA, Hawai‘i, June 09, 2026 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today announced the appointment of Ryan Panopio as the Company’s Chief Investment Officer effective June 3, 2026.

Emerson at Red Oak, a newly constructed townhome-style apartment community south of Dallas, marks PEM's continued conviction in high-growth Texas submarkets anchored by one of the nation's fastest-expanding technology corridors.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (“Grail” or the “Company”) (NASDAQ: GRAL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

SAN FRANCISCO, June 09, 2026 (GLOBE NEWSWIRE) -- After helping 306 businesses make more than 818,000 calls during beta, Close today announced the general availability of Chloe, an AI sales agent built directly into the CRM, now available on all plans for customers in the U.S. and Canada.

DALLAS, June 09, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (NASDAQ: APLD) (“Applied Digital” or the “Company”), a leading designer, builder and operator of high-performance, sustainably engineered data centers and colocation services for Artificial Intelligence (“AI”), networking, and blockchain workloads, today announced that its subsidiary, APLD ComputeCo 3 LLC (“APLD ComputeCo 3”), has priced a $1.59 billion offering (the “Offering”) of 7.000% senior secured notes due 2031 (the “Notes”) at par. The Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act. The Offering is expected to close on or around June 16, 2026, subject to market and other conditions.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Verra Mobility Corporation (“Verra” or the “Company”) (NASDAQ: VRRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Einride American Depositary Shares and warrants to trade on Nasdaq under the symbols "ENRD" and “ENRDW” respectively

Large returning fleet customer places $3 million order for 12 Xos Hub mobile energy storage and charging units, enabling rapid electrification of one of the world’s fastest-growing autonomous mobility fleets with no permanent utility upgrades required

HIGHLIGHTS

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Gap Inc. (“Gap” or the “Company”) (NYSE: GAP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Compass, Inc. (“Compass” or the “Company”) (NYSE: COMP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

HOUSTON, June 09, 2026 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCQB: HYOR) today announced it has retained Stonegate Capital Partners ("Stonegate") to lead its investor relations program, expand institutional research coverage, and provide strategic capital markets advisory services.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Priority Income Fund, Inc. (“Priority Income Fund” or the “Fund”) announced today that the Fund’s Board of Directors has declared distributions on shares of the Fund’s 7.00% Series D Term Preferred Stock due 2029 (“Series D”), 7.000% Series K Cumulative Preferred Stock (“Series K”), and 6.375% Series L Term Preferred Stock due 2029 (“Series L”).

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Photronics, Inc. (“Photronics” or the “Company”) (NASDAQ: PLAB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Badger Meter, Inc. (“Badger Meter” or the “Company”) (NYSE: BMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against PicS N.V. (“PicS” or the “Company”) (NASDAQ: PICS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Helen of Troy Limited (“Helen of Troy” or the “Company”) (NASDAQ: HELE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wise Group plc (“Wise” or the “Company”) (NASDAQ: WSE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Recognition highlights the Company’s progress toward commercial fusion energy as it advances plans to become a public company

TOKYO and NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Mitsubishi HC Capital Inc. (“Mitsubishi HC Capital”) and Brookfield Asset Management Ltd. (“Brookfield”) today announced the formation of a joint venture for a privately held renewable energy company (the “JV”) that will acquire and operate a diversified portfolio of contracted, operating renewable energy assets in Europe.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today announced that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to lasmecabtagene timgedleucel (lasme-cel), its CD22-targeting allogeneic CAR-T cell therapy product candidate, for the treatment of patients with relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Borr Drilling Limited (“Borr” or the “Company”) (NYSE: BORR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GDS Holdings Limited (“GDS” or the “Company”) (NASDAQ: GDS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Deploys Unitree G1 Humanoid Robots to Build Proprietary Enterprise Datasets; Integrates Automation into Core IFM Platform for Scalable Revenue Growth

AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced that it has commenced a public offering of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, Shattuck expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock at the public offering price, less underwriting discounts and commissions. The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All of the securities are being offered by Shattuck.

Proposed Strategic Acquisition Represents a Major Industry Expansion as Company Advances Toward Public Listing

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Xcel Brands, Inc. today announced an exclusive licensing collaboration between handbag specialist Baggallini and internationally renowned model, entrepreneur, and fashion icon Coco Rocha. The partnership will begin with the launch of a limited-edition capsule collection designed by Coco Rocha for the modern woman.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AECOM (“AECOM” or the “Company”) (NYSE: ACM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

PHILADELPHIA, June 09, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context has granted a non-qualified stock option award to purchase 146,000 shares of its common stock to a new employee as an inducement material for accepting employment with Context.

Net sales increased 22.5% year-over-year to $107.1 million

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Keel Infrastructure Corp. (NASDAQ/TSX: KEEL), a North American digital and energy infrastructure company (“Keel” or the “Company”), today announced that it has closed its offering of $458 million aggregate principal amount of 1.250% convertible senior notes due 2032 (the “Convertible Notes”), which includes the exercise in full of the $58 million option granted to the initial purchasers of the Convertible Notes.

MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced plans to participate in the upcoming Planet MicroCap Las Vegas 2026 Conference.

Represents a foundational step in Dave's capital strategy, reducing direct funding obligations, lowering cost of capital and unlocking substantial liquidity for capital allocation priorities 

BOISE, Idaho, June 09, 2026 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced the appointment of Dr. Alexis Black Björlin to its board of directors.

Irving, TX, June 09, 2026 (GLOBE NEWSWIRE) -- Breeze Acquisition Corp. II (NASDAQ: BREZU) (the “Company”) announced today that, on June 11, 2026, the Company’s units will no longer trade, and that the Company’s ordinary shares and rights, which together comprise the units will commence trading separately. The ordinary shares and rights will be listed on the Nasdaq Global Market and trade with the ticker symbols “BREZ” and “BREZR”, respectively. This is a mandatory and automatic separation, and no action is required by the holders of units.

LONDON, June 09, 2026 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (“Marex”), a diversified global financial services platform, today announced that it has completed its offering (the “Offering”) of U.S.$500 million perpetual subordinated resettable fixed rate notes (the “Notes”).

MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOD) (“Vireo” or the “Company”) today announced the appointment of BDO USA, P.C. (“BDO”) as the Company’s new independent registered public accounting firm, effective immediately. The appointment follows the Company’s dismissal of Davidson & Company, LLP (“Davidson”) as the Company’s independent registered public accounting firm, effective June 5.

MENLO PARK, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for May 2026.

Paul Miller Rejoins Grocery Outlet as Chief Purchasing and Merchandising OfficerIan Ferry Promoted to Chief Financial OfficerCompany Affirms Second Quarter and Fiscal 2026 Outlook

SUNNYVALE, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Cerebras Systems Inc. (Nasdaq: CBRS), maker of the world’s fastest AI infrastructure, announced it will release first-quarter 2026 financial results, after the market closes on Tuesday, June 23, 2026.

Southfield, Michigan, June 09, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that we have extended the maturity of our revolving secured line of credit facility with a commercial bank syndicate from June 22, 2028 to June 22, 2029. The interest rate on borrowings under the facility was decreased from the Secured Overnight Financing Rate (“SOFR”) plus 197.5 basis points to SOFR plus 175 basis points.

Q1 FY27 Net Sales of $47.4 Million; Fire Services Grew 11%

Mechelen, Belgium; June 9, 2026, 22:01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced the launch of a share repurchase program (the “Program”), under which the Company may repurchase ordinary shares for an aggregate amount of up to €50 Million. Repurchases under the Program may be made no later than December 31, 2026. The Program is entered into with Morgan Stanley & Co International PLC.  

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, "Company", “our”, or “we”) today announced that it held its special meeting of stockholders (the “Special Meeting”) on June 9, 2026. The proposals that were considered at the Special Meeting are described in detail in the Company’s definitive proxy statement for the Special Meeting as filed with the Securities and Exchange Commission on March 11, 2026 (the “Proxy”). As of March 11, 2026, there were 486,484,945 shares of the Company's common stock outstanding, 25,394,532 shares of the Company’s 5.50% Series A1 Preferred Stock outstanding (the “Series A1 Preferred Stock”), 163,000 shares of the Company’s 5.50% Series A2 Preferred Stock outstanding (the “Series A2 Preferred Stock”), 5,251,157 shares of the Company’s 5.35% Series A Fixed Rate Cumulative Perpetual Preferred Stock outstanding (the “5.35% Series A Preferred Stock”), 908,259 shares of the Company’s 5.50% Series M1 Preferred Stock outstanding (the “Series M1 Preferred Stock”), 23,376,070 shares of the Company’s 6.50% Series A3 Preferred Stock outstanding (the “Series A3 Preferred Stock”), 1,794,312 shares of the Company’s 6.50% Series M3 Preferred Stock outstanding (the “Series M3 Preferred Stock”), 6,920,261 shares of the Company’s Floating Rate Series A4 Preferred Stock outstanding (the “Series A4 Preferred Stock”), 1,995,546 shares of the Company’s Floating Rate Series M4 Preferred Stock outstanding (the “Series M4 Preferred Stock”), 3,341,380 shares of the Company’s 7.50% Series A5 Preferred Stock outstanding (the “Series A5 Preferred Stock”) and 878,753 shares of the Company’s 7.50% Series M5 Preferred Stock outstanding (the “Series M5 Preferred Stock”). Each share of common or preferred stock has one vote. To afford additional time to solicit stockholder votes for the proposal found in the Proxy, the Special Meeting has been adjourned until June 23, 2025, at 5:00 p.m., Eastern Time, at www.virtualshareholdermeeting.com/PSEC2026SM. 

Article R. 22-10-23 of the French Commercial Code

Daix (France), New York City (New York, United States), June 9,2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the availability of the preparatory documents for the Combined General Meeting of June 30, 2026.

Combining High Heat Dissipation with High Voltage Support

CEO Clayton Thomas and Founder Dr. Christina Rahm are recognized at the 2026 American Business Awards® in New York City.

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) --